技术辅助强化家庭治疗：可行性研究
Technologically assisted intensive home treatment: feasibility study.
作者信息
Caspi Asaf, Tzur Bitan Dana, Halaly Ofir, Hallaly Ofri, Friedlander Avraham, Barkai Galia, Zimlichman Eyal, Stein Orit, Shani Mordechai, Amitai Ziv, Ansbacher Tsofiya, Weiser Mark
机构信息
The Drora and Pinchas Zachai Division of Psychiatry, Sheba Medical Center, Ramat Gan, Israel.
Department of Behavioral Sciences, Ariel University, Ariel, Israel.
出版信息
Front Psychiatry. 2023 Jul 27;14:1196748. doi: 10.3389/fpsyt.2023.1196748. eCollection 2023.
INTRODUCTION
In recent year, many attempts have been made to provide patients with alternatives to psychiatric hospitalization during acute distress. Although several hospitalization alternatives have been offered, most of them still require patients to be distanced from their families, friends, and the social environment.
METHODS
In this report we describe the implementation of a novel approach to psychiatric care termed "Technologically assisted Intensive Home Treatment", where patients arriving to emergency settings are directed to home care with technological aids that enable close monitoring and ongoing contact with their therapists.
RESULTS
We describe the rationale and treatment principles of the treatment, and provide an elaborative description of the implementation process during the first year of implementation.
DISCUSSION
Additional attention is given to factors associated with early dropout from the program, in order to inform readers of predictors to optimal care. Limitations and directions for future research and practice are discussed. The study was registered in the database of clinical trials (registration number SHEBA-19-6555-MW-CTIL) and in the Ministry of Health (registration number MOH_2022-08-22_011992).
引言
近年来，人们多次尝试在患者急性痛苦期间为其提供精神科住院治疗的替代方案。尽管已经提供了几种住院替代方案，但其中大多数仍然要求患者与家人、朋友和社会环境保持距离。
方法
在本报告中，我们描述了一种名为“技术辅助强化家庭治疗”的新型精神科护理方法的实施情况，即到达急诊室的患者被引导至家庭护理，并配备技术辅助设备，以便对其进行密切监测并与治疗师保持持续联系。
结果
我们阐述了该治疗方法的基本原理和治疗原则，并对实施第一年的实施过程进行了详细描述。
讨论
我们额外关注了与该项目早期退出相关的因素，以便让读者了解最佳护理的预测因素。讨论了研究的局限性以及未来研究和实践的方向。该研究已在临床试验数据库（注册号SHEBA-19-6555-MW-CTIL）和卫生部（注册号MOH_2022-08-22_011992）注册。
Zotero 插件